Introduction: Urinary tract infection is the most frequent complication occurring in patients with spinal cord injuries and can cause renal failure and male infertility. We used the urinary a-1-microglobulin (a1Mg) as a marker for pyelonephritis and the serum prostate speci®c antigen (PSA) as a marker for prostatitis with reference to the currently available methods. The aim of our study is (1) to dierentiate between upper (pyelonephritis) and lower urinary tract infection (cystitis, prostatitis) in neurogenic bladder disease, (2) to determine if high (438.58C) fever in a neurogenic bladder disease patient was due to urological (prostatitis, pyelonephritis) causes or not.
Introduction
Even with modern treatment modalities, urinary tract infection (UTI) remains a frequent complication (57 ± 62%) after spinal cord injury.
1,2 Symptomatic infections occur in 22 to 45% of the patients. 1, 2 UTIs are not only a frequent pathology in this patient group but can cause severe complications such as renal damage and infertility. 3 The diagnosis and/or localization of a UTI in patients with neurogenic bladder disease is often uncertain because of the lack of speci®c symptomatology and because several other diseases cause high fever in these patients (tissue sores, pulmonary infections, and orthopedic infections).
Localization of an upper tract infection can be achieved with a CT scan of the kidneys, an isotopic scan of the kidneys, or a bladder wash-out test.
sound are only helpful in diagnosing prostatic abscess formation. In neurogenic bladder disease, prostatitis can only be diagnosed by ®ve glass-specimen tests or prostatic biopsy, 8 neither of which can be performed during acute prostatitis because of the risk of septicemia. In neurogenic bladder disease, an accessible, quick and safe procedure is needed to diagnose and localize a UTI.
Acute pyelonephritis is an acute focal interstitial nephritis, secondary to an ascending infection, leading to tubular dysfunction at several levels (collecting tubules, proximal tubules). Acute pyelonephritis damages the proximal renal tubules, which causes leakage of tubular proteins 9 ± 11 and renal enzymes 12, 13 into the urine. Renal enzymes (b-N-acetyl glucosaminidase) have not proven to be useful in the localization of a urinary tract infection in spinal cord injury patients. 12 We have been unable to ®nd any studies of tubular proteins in neurogenic bladder disease patients. Serum proteins with a molecular mass of less than 40 000 Da easily cross the glomerular membrane and are subsequently reabsorbed by the renal tubule so that only extreme low quantities are found in normal urine. Damage of the proximal tubule will result in leakage of these small proteins into the urine. Pyelonephritis is known to damage the proximal tubule and could therefore be diagnosed or followed by measuing these small proteins in urine. Any damage of the tubules (eg interstitial nephritis, heavy metal poisoning, diabetes, renal insuciency, aminoglycosides, contrast media and chemotherapy) will lead to the appearance of these proteins in the urine. For the diagnosis of pyelonephritis we have chosen the tubular protein a-1-microglobulin because of its stability (even at room temperature), its determination by immunonephelometry, and the accessibility of the method.
The prostate speci®c antigen (PSA) is a speci®c prostatic marker. The reference range in serum is less than 4 ng/ml, and its concentration rises in prostate cancer, trauma, or infection.
14 Even physical exercise, digital rectal examination, and cytoscopy may increase the serum PSA levels. 14, 15 Because this is an extremely sensitive parameter, traumatic catheterization and even non-traumatic intermittent catheterization can give false high PSA serum levels. The use of this parameter in the diagnosis of prostatitis does not seem to have been reported in the literature.
The aim of our study is (1) to dierentiate between upper urinary tract infection (pyelonephritis) and lower urinary tract infection (cystitis, prostatitis) in neurogenic bladder disease, (2) to determine if high (438.58C) fever in a neurogenic bladder disease patient was due to urological (prostatitis, pyelonephritis) causes or not. We used the urinary a-1-microglobulin (a1Mg) as a marker for pyelonephritis and the serum prostate speci®c antigen (PSA) as a marker for prostatitis with reference to the currently available methods (clinical evidence, urography, CTscan, bladder wash-out test, ®ve glass-specimen test).
Patients and methods

Patients
Between December 1994 and June 1996, we evaluated 124 patients (74% male, 16% female; age 30+17 years) with a neuropathic bladder and a UTI. Our patient group was predominantly spinal cord injury patients with paraplegia (n=58) or tetraplegia (n=30), meningomyeloceles (n=16), or other neurological diseases (n=20). Exclusion criteria were renal insufficiency, diabetes, nephrotoxic medication (aminoglucocides, chemotheraphy), prostatic hypertrophy, prostatic cancer or traumatic catheterization (within 2 weeks). We also evaluated 16 patients with clam-bladder augementation with an asymptomatic urinary-tract infection.
The localization of the UTI was done clinically in 26 patients with partial or complete preservation of pain sensation (acute pyelonephritis: n=6, acute prostatitis: n=3, cystitis: n=15). The bladder washout test alone or in combination with ®ve glassspecimen tests was used in 77 patients (acute pyelonephritis: n=15, prostatitis: n=12, cystitis: n=50). Intravenous urography was used in nine patients (chronic pyelonephritis: n=9) and CT scan of the kidneys (diagnosis of acute pyelonephritis) in 11 patients (acute pyelonephritis: n=6, acute prostatitis: n=2, cystitis: n=3). In 1 patient, the diagnosis of prostatic abscess formation was made with a transrectal ultrasonography.
Control population
The control population consisted of 14 healthy patients with a neuropathic bladder. They had no urinary tract infection. They were mainly spinal cord injured patients (n=12), and two had meningomyelocele (nine males, ®ve females; age 28+13 years).
We also evaluated nine patients, (®ve males, four females; 31+12 years) with neurogenic bladder disease (eight had a spinal cord injury and one had a meningomyelocele) and high fever (438.58C) due to in¯uenza (n=2), pneumonia (n=5), or resorption of huge hematoma (n=2). None of them had a UTI.
The control population for the serum PSA study were 26 male patients (31+16 years) with a neurogenic bladder suering from cystitis.
Methods
The diagnosis of UTI was accepted if more than 100 000 CFU (Kass, 1956) were found with signi®cant pyuria (45 white blood cells).
The clinical diagnosis of acute cystitis was only made in patients known to have sterile urine in the foregoing period and who developed acute symptoms of strangury, urgency, or incontinence in association with the diagnosis of UTI. The clinical diagnosis of chronic cystitis was made in patients with a chronic UTI who had had no episodes of fever for the last year and who had no urological symptoms. The clinical diagnosis of acute pyelonephritis was made if UTI was associated with high fever (438.58C) and ank pain comparable with a renal colic. Acute prostatitis was diagnosed clinically if the patient complained of dysuria, urgency, perineal pain and urethral discharge.
Chronic pyelonephritis was diagnosed by intravenous urography when typical lesions such renal scarring and dilatation were seen. Acute pyelonephritis was diagnosed with a CT scan using contrast media. Typical lesions (renal abscess, wedge-shaped zones of increased and decreased enhancement, illde®ned zones of low attenuation, enlarged kidney with or without decreased parenchymal enchancement) as described by Soulen et al 4 were used. Both tests are considered gold standards for this purpose. 5 A UTI can be localized in neurogenic bladder disease using the wash-out test 7 in females and in combination with ®ve glass-specimen tests in males. 8 The techniques were described by Wyndaele et al 7, 8 and have been used in our department since 1979. These tests cannot be considered the gold standard as their sensitivity and aspeci®city are unknown. However, no other diagnostic tools exist to diagnose prostatitis in neurogenic bladder disease. Five glassspecimen tests cannot be performed during acute prostatitis due to the high risk of septicemia. Therefore, patients known with chronic prostatitis who have a high fever (438.58C) together with increasing pyuria and bacteruria were considered as having acute prostatitis. In doubtful cases (n=2) (re¯ux, stone disease, former upper tract infections), a CT scan was performed to demonstrate the absence of acute pyelonephritis.
The urinary a-1-microglobulin was detected by latex-enhanced nephelometry (Behringwerke, Marburg, Germany). Reference values are 0 ± 8 mg/liter. The concentration of the urinary a1Mg was also expressed as the urinary a1Mg/creatinine ratio. The serum PSA was detected with a radio immunoassay (Tandem-R PSA Hybritech Europe SA, LieÁ ge, Belgium). The cut-o value was 4 ng/ml.
We compared the urinary a1Mg and the serum PSA of patients with cystitis to the urinary a1Mg and the serum PSA in patients with acute pyelonephritis, chronic pyelonephritis, and prostatitis with fever. The control population was used to prove that high fever and cystitis do not cause an increase of the urinary a1Mg. We also looked to the value of the urinary a1Mg in patients with an intestinal segment in the urinary tract and the in¯uence on intermitent catheterization on the serum PSA.
Data are given as median (lower quartile-upper quartile). Comparison between groups was done with the Wilcoxon test. Analysis of sensitivity and speci®city was performed using the receiver operator curve (ROC). All individual results and medians with lower and upper quartiles for the subpopulations are given in Figure 1 .
Results
Urinary a1Mg in the control population, in patients with high fever but without UTI and in patients with cystitis In the control population (n=14), the urinary a1Mg concentration was 5 mg/1 (5 ± 5 mg/l) and the urinary a1Mg/creatine ratio was 0.012 (0.007 ± 0.018). In the nine patients with high fever (438.58C) and without a UTI we found a urinary a1Mg concentration of 5 mg/l (5 ± 9 mg/l) and a urinary a1Mg/creatinine ratio of 0.007 (0.005 ± 0.011). Table 1 shows that there were no dierences in this respect between these two groups. Results are depicted in Figure 1 . Table 1 gives the results of the urinary a1Mg excretion (6 mg/l (5 ± 10 mg/l)) and the urinary a1Mg/ creatinine ratio (0.01 (0.005 ± 0.02)) in the cystitis group (n=52). No signi®cant dierence could be found between the control population and the cystitis group. Results are also depicted in Figure 1 .
Urinary a1Mg in acute pyelonephritis or in exacerbation of chronic pyelonephritis In these patients (n=27), there was a signi®cant increase of the urinary a1Mg concentration (20 mg/l (16 ± 28 mg/l)) and the urinary a1Mg/creatinine ratio (0.031 (0.019 ± 0.056)). The results are listed in Table 2 Figure 1 Urinary alpha-1-microglobuline concentrations in 147 patients with neurogenic bladder disease Figure 1 . Of these 27 patients, 24 had a proven acute pyelonephritis and three had an exacerbation of their chronic pyelonephritis with high fever (438.58C).
The receiver operator curve was made for the results of the urinary a1Mg concentration in patients with pyelonephritis versus patients with cystitis (sensitivity 96%, speci®city 73%) and versus the control population (sensitivity 96%, speci®city 93%) ( Table 2) .
In six patients, we followed the urinary a1Mg levels until normalization. After 2 to 3 days, the urinary a1Mg levels tend to normalize and 5 days later all urine samples were within reference limits.
Urinary a1Mg in patients with chronic pyelonephritis, prostatitis with fever and in patients after a clam bladder augmentation Table 2 gives the results of patients with chronic pyelonephritis (n=13: 7 mg/l (5 ± 20 mg/l)) and prostatitis with fever (n=16: 7 mg/l (5 ± 15.3 mg/l)). Table 1 lists the patients with cystitis and a clam bladder (n=16: 5 mg/l (5 ± 6 mg/l)) versus patients with cystitis without an augmented bladder (n=52: 6 mg/l (5 ± 10 mg/l)). There was no statistical significant dierence of the urinary a1Mg concentration and the urinary a1Mg/creatinine ratio between these groups relative to the cystitis group. Results are depicted in Figure 1 .
Serum PSA in prostatitis, acute pyelonephritis and cystitis A signi®cant (P50.01) increase in serum PSA was found in the prostatitis group (11.5 ng/dl (6.75 ± 24 ng/dl)) versus the cystitis group (1.39 ng/dl (0.55 ± 2.32 ng/dl)). For the serum PSA, we found a sensitivity of 69% and speci®city of 96% in the dierential diagnosis between prostatitis and cystitis.
No signi®cant elevated serum PSA was found in the pyelonephritis group (1.35 ng/dl (0.93 ± 1.81 ng/dl)).
From the 26 patients with cystitis, 16 performed intermittent catheterization (PSA=1.46 ng/dl (1.08 ± 1.82 ng/dl)) and 10 used straining or suprapubic catheterization to empty their bladders (PSA= 0.58 ng/dl (0.49 ± 2.32 ng/dl)). No signi®cant difference in serum PSA between these groups was found.
The urinary a1Mg and the serum PSA in the dierential diagnosis of pyelonephritis and prostatitis In the dierential diagnosis between prostatitis and pyelonephritis we found a sensitivity of 96% and a speci®city of 56% for the urinary a1Mg concentration (cut-o value 8 mg/l) and a sensitivity of 68% and speci®city o 100% for the serum PSA (cut-o value 4 ng/ml). The best discriminative parameter we found between acute pyelonephritis and prostatatis is the urinary a1Mg per serum PSA ratio. Plotting these a1Mg/PSA ratios in the receiver operator curve gives a sensitivity of 92% and speci®city of 88% with a cut-o value of 5000 mg/l.
Discussion
In the literature, tubular proteinuria and urinary enzymuria have been reported to be sensitive and speci®c markers for tubular damage.
9 ± 11,13 Using urinary enzymes have not been found to be useful in the diagnosis of upper tract infection in spinal cord injury patients. 12 In our patient group with neurogenic bladder disease, we found the urinary a1Mg to be a highly sensitive (96%) and speci®c (93%) marker of upper tract infection. Positive results can also be generated by other causes of tubular damage 9 ± 11,13 like renal failure, diabetes, nephrotoxic drugs (aminoglycosides, chemotherapy, contrast media), heavy metal intoxication, myeloproliferative diseases, and AIDS. The eect of concentration or dilution of urine can theoretically be minimized when using the urinary a1Mg/creatinine ratio but reduced the sensitivity and speci®city in our series. Proteinuria (glomerular and tubular proteins) increases during fever, which is not just due to the urine concentration. 9 The urinary a1Mg has been proven to be the marker that is the least in¯uenced by fever. 9 This observation was con®rmed by our data (control group with fever and without UTI). Finally, the dosage of a1Mg was not in¯uenced by the variability of urinary composition and remains stable at room temperature for a long time. For all these reasons we found the urinary a1Mg to be a very practical and reliable marker of acute pyelonephritis.
The bladder wash-out test and the ®ve glassspecimen tests cannot be considered gold standards. 7, 8 Their speci®city and sensitivity is unknown, which is re¯ected in our results. In the dierential diagnosis between prostatatis and cystitis, the serum PSA has a rather low sensitivity (69%) and a high speci®city of 96% (Table 3) . As no accurate tool exists for the diagnosis of acute prostatitis in neurogenic bladder disease, 8 a certain percentage of misdiagnoses will occur. As the serum PSA is known to be an extremely sensitive parameter (digital rectal examination, physical exercise, and cystoscopy increases the serum PSA), 14, 15 its sensitivity for the diagnosis prostatitis', must be higher than 69%.
In the dierential diagnosis between pyelonephritis and prostatitis, the serum PSA had high speci®city (100%) and low sensitivity (68%). In the pyelonephritis group, no patient had a serum PSA above 4 ng/ml. In the prostatitis group 5/16 patients had a normal serum PSA. This can be explained by the rather low sensitivity and speci®city of the diagnosis prostatitis' by all other means used. 7, 8 The sensitivity of the urinary a1Mg in the dierential diagnosis between pyelonephritis and prostatitis was 96% and the speci®city was 56%. Although pyelonephritis was excluded, 3/16 patients with prostatitis and high urinary a1Mg concentrations were found. All three patients had a high fever (39.58 to 408C) and had been ill for several days while the other patients were seen at the onset of the disease. Therefore, in male patients with a UTI and fever, one should always determine, both urinary a1Mg and the serum PSA. If a male patient has a urinary a1Mg above 8 mg/l and a serum PSA 54 ng/ml, we diagnose pyelonephritis. If both the urinary a1Mg and serum PSA are elevated we can diagnose prostatitis but a concomitant pyelonephritis is not excluded.
Most of our patients perform intermittent catheterization to achieve continence as much as possible. Therefore, the in¯uence of intermittent catheterization on the serum PSA is an important factor. Indeed, digital rectal examination or cystoscopy increase the serum PSA.
14 Even physical exercise (bicycle ergometer) can cause a threefold increase of serum PSA, which is likely due to squeezing of the prostate gland. 15 Intermittent catheterization did not in¯uence the serum PSA in our series. The median serum PSA concentration was slightly higher in the group that performs intermittent catheterization but this was not statistically signi®cant and the upper quartile (1.81 ng/ ml) was largely below 4 ng/ml. Traumatic catheterization could cause an important increase of the serum PSA as does cystoscopy, so these patients were ruled out of the study.
With increasing age, a higher incidence of prostatic hypertrophy and of prostate cancer is seen. Both pathologies are responsible for elevated serum PSA values.
14 Above 45 years of age one should always rule out a prostatic hypertrophy or a cancer as a cause of PSA elevation (above 4 ng/ml). As prostate volume increases with age, the PSA will increase with age too and therefore, a serum PSA of 6 ng/ml will be of less diagnostic value of prostatitis at the age of 50 than at the age of 20. As our population (predominance of spinal cord injury patients and meningomyeloceles) is relatively young (30+17 years), the age-related PSA elevation did not in¯uence our results.
The diagnosis and localization of a UTI in a neurogenic bladder disease patient with urinary a1Mg and serum PSA have the advantages that no transportation of the patient is necessary, that the method is readily accessible and cheaper (also in combination with the PSA), and that no contrast media, tracers, or X-rays are needed. After starting antibiotics, the urinary a1Mg stays high for up to 5 days whereas the serum PSA stays high for 2 weeks or more.
14 This means that even if empiric antibiotics were started before a urine culture and sediment were taken (which normalize within 24 h after the onset of antibiotics), a post hoc diagnosis of pyelonephritis or prostatitis can be made.
Conclusion
The urinary a1Mg is a highly speci®c and sensitive marker for pyelonephritis. The urinary a1Mg can distinguish if fever is from urological causes or not. In man a serum PSA must be taken. The serum PSA is 
